Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2915 ARTíCULOS , VIENDO DEL 2836 AL 2850

PUBMED

Establishing an evidence-base framework for driving rehabilitation in Parkinson's disease: A systematic review of on-road driving studies.

Devos H, Ranchet M, Emmanuel Akinwuntan A, Uc EY.

NeuroRehabilitation. 2015;37(1):35-52. doi: 10.3233/NRE-151239. Review.

0

0

0

PUBMED

Failure of stop and go in de novo Parkinson's disease--a functional magnetic resonance imaging study.

Vriend C, Gerrits NJ, Berendse HW, Veltman DJ, van den Heuvel OA, van der Werf YD.

Neurobiol Aging. 2015 Jan;36(1):470-5. doi: 10.1016/j.neurobiolaging.2014.07.031.

0

0

0

PUBMED

Neurodegeneration and cognition in Parkinson's disease: a review.

Ding W, Ding LJ, Li FF, Han Y, Mu L.

Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2275-81. Review.

0

0

0

PUBMED

Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease.

Critchley RJ, Khan SK, Yarnall AJ, Parker MJ, Deehan DJ.

Br Med Bull. 2015 Sep;115(1):135-42. doi: 10.1093/bmb/ldv029. Review.

0

0

0

PUBMED

Autonomic nervous system response to L-dopa in patients with advanced Parkinson's disease.

Ruonala V, Tarvainen MP, Karjalainen PA, Pekkonen E, Rissanen SM.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:6162-5. doi: 10.1109/EMBC.2015.7319799.

0

0

0

PUBMED

Multidisciplinary rehabilitation in Parkinson's disease: A milestone with future challenges.

Rochester L, Espay AJ.

Mov Disord. 2015 Jul;30(8):1011-3. doi: 10.1002/mds.26277. No abstract available.

0

0

0

PUBMED

CHCHD2 and Parkinson's disease.

Jansen IE, Bras JM, Lesage S, Schulte C, Gibbs JR, Nalls MA, Brice A, Wood NW, Morris H, Hardy JA, Singleton AB, Gasser T, Heutink P, Sharma M; IPDGC..

Lancet Neurol. 2015 Jul;14(7):678-9. doi: 10.1016/S1474-4422(15)00094-0. No abstract available.

0

0

0

PUBMED

[Key messages to promote positive living with Parkinson's disease in the community].

Portillo MC, Ursúa Sesma ME, Díaz de Cerio Ayesa S; grupo investigador Programa ReNACE..

Aten Primaria. 2015 May;47(5):322-3. doi: 10.1016/j.aprim.2014.06.004. Spanish. No abstract available.

0

0

0

PUBMED

Resistance versus Balance Training to Improve Postural Control in Parkinson's Disease: A Randomized Rater Blinded Controlled Study.

Schlenstedt C, Paschen S, Kruse A, Raethjen J, Weisser B, Deuschl G.

PLoS One. 2015 Oct 26;10(10):e0140584. doi: 10.1371/journal.pone.0140584.

0

0

0

PUBMED

Role of G-protein coupled receptor kinase 5 gene in cognitive impairment in Parkinson's disease.

Nicoletti G, De Luca V, Tarantino P, Gagliardi M, Iannello G, Novellino F, Morelli M, Annesi G, Quattrone A.

Psychiatry Res. 2015 Dec 30;230(3):975-7. doi: 10.1016/j.psychres.2015.11.026.

0

0

0

PUBMED

Specific brainstem and cortico-spinal reflex abnormalities in coexisting essential tremor and Parkinson's disease (ET-PD).

Yavuz D, Gündüz A, Ertan S, Apaydın H, Şifoğlu A, Kiziltan G, Kiziltan ME.

Neurophysiol Clin. 2015 May;45(2):143-9. doi: 10.1016/j.neucli.2015.01.001.

0

0

0

PUBMED

Placebo effect in Parkinson's disease: Harnessing the mind in the treatment of PD.

Udupa K, Fox SH.

Mov Disord. 2015 May;30(6):786. doi: 10.1002/mds.26222. No abstract available.

0

0

0

PUBMED

Cognitive functions and stereopsis in patients with Parkinson's disease and Alzheimer's disease using 3-dimensional television: a case controlled trial.

Lee CN, Ko D, Suh YW, Park KW.

PLoS One. 2015 Mar 30;10(3):e0123229. doi: 10.1371/journal.pone.0123229.

0

0

0

PUBMED

Voxel-based morphometry of the marmoset brain: In vivo detection of volume loss in the substantia nigra of the MPTP-treated Parkinson's disease model.

Hikishima K, Ando K, Komaki Y, Kawai K, Yano R, Inoue T, Itoh T, Yamada M, Momoshima S, Okano HJ, Okano H.

Neuroscience. 2015 Aug 6;300:585-92. doi: 10.1016/j.neuroscience.2015.05.041.

0

0

0

PUBMED

Neurological morphofunctional differentiation induced by REAC technology in PC12. A neuro protective model for Parkinson's disease.

Maioli M, Rinaldi S, Migheli R, Pigliaru G, Rocchitta G, Santaniello S, Basoli V, Castagna A, Fontani V, Ventura C, Serra PA.

Sci Rep. 2015 May 15;5:10439. doi: 10.1038/srep10439.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy